Speaker Profile
PHARMD, Associate Chief Consultant Clinical Pharmacy, VA, San Diego
Biography
Dr. Morreale has been entrusted with organizing, standardizing and expanding the scope of clinical pharmacy practice nationally since 2010. In recent years this has included the integration of pharmacogenomics into clinical practice for pharmacists in all practice settings. In 2018 he took on the added responsibility of overseeing national policy development and maintenance for the which also involves developing and implementing practice changes, policy, regulations and guidance. Prior to this national position he served as Chief and Associate Chief of Pharmacy for a large Healthcare System and its satellite facilities for nearly 20 year giving him a great deal of experiencing in running and managing a highly complex pharmacy organization. He is well versed in the legal, regulatory, and operational aspects and challenges facing such organizations.
Talk
Integration of pharmacogenomic (PGx) testing into clinical practice has accelerated, moving it from a novelty to a standard part of patient care. As PGx testing becomes a standard of care, failure to integrate it into patient care practice could lead to instances where care may not be optimized, raising potential malpractice issues.
Session Abstract – PMWC 2023 Silicon Valley
Track Co-Chair:
Mary Relling, St. Jude
Pharmacists have long recognized that using unique patient characteristics to guide pharmacotherapy decision-making can improve drug response and mitigate drug-associated risks. Age, weight, and dietary habits were among the first patient-specific characteristics used to individualize pharmacotherapy. As technologies advanced, analytic tools that measure surrogate markers of liver and renal function, together with drug concentrations in biological fluids, were adopted to optimize therapeutic regimens. Cutting-edge genomic technologies are now being integrated into patient care for the selection of targeted therapies and identification of those at increased risk of poor pharmacotherapy outcomes. We’re excited to bring together experts who are advancing pharmacogenomics at scale through cutting edge clinical implementation, research, and education.
- PMWC 2023 PGx Award Ceremony:
Pioneer Honoree: Dan Roden, Vanderbilt University Medical Center
Luminary Honoree: Kelly E. Caudle, St. Jude
- Fireside Chat:
PMWC 2023 Pioneer Honoree Dan Roden, Vanderbilt University Medical Center with Mary Relling, St. Jude - Keynote by PMWC 2023 Luminary Honoree:
- Kelly E. Caudle, St. Jude - Fireside Chat:
Chair: Damon Hostin, Illumina
- Howard McLeod, Intermountain Health - Laboratory Testing and Reports
Chair: Kristy Crooks, University of Colorado
- Ann M. Moyer, Mayo Clinic
- Stuart Scott, Stanford University
- Implementation of PGx at UCSF
- Bani Tamraz, UCSF
- From Economics to Reimbursement (PANEL)
Chair: Sara Rogers, American Society of Pharmacovigilance
- Stirling Bryan, The University of British Columbia
- Ray Stultz, Optum
- Gabriel Bien-Willner, Palmetto GBA
- Policy Efforts to Address Barriers to PGx Adoption
Chair: Kristine Ashcraft, Invitae
- Pam Traxel, ACS CAN - PGx Practice Liability
Chair: Dan Hertz, University of Michigan
- Anthony Morreale, VA, San Diego
- Karen Merritt, Patient Advocate - Diversity, Equity, and Inclusion in Pharmacogenomics Implementation
- Carlos Bustamante, Galatea Bio
- Kathy Giacomini, UCSF - Implementation of PGx Program & PGx Clinic Services in a Large Rural Healthcare Setting
- April Schultz, Sanford
